CGEM
Cullinan Oncology Inc

449
Mkt Cap
$633.3M
Volume
552,823.00
52W High
$13.33
52W Low
$5.68
PE Ratio
-2.95
CGEM Fundamentals
Price
$10.87
Prev Close
$10.72
Open
$10.70
50D MA
$10.21
Beta
1.13
Avg. Volume
1.18M
EPS (Annual)
-$3.11
P/B
1.42
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Down 6.2% - Here's What Happened
Cullinan Therapeutics (NASDAQ:CGEM) Shares Down 6.2% - Should You Sell...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Trading Up 3.9% - What's Next?
Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Up 3.9% - Here's Why...
MarketBeat·20d ago
News Placeholder
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are covering the stock, Marketbeat.com reports. One...
MarketBeat·21d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) CEO Sells $99,319.22 in Stock
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) CEO Nadim Ahmed sold 9,922 shares of the firm's stock in a transaction dated Tuesday, December 23rd. The stock was sold at an average price...
MarketBeat·22d ago
News Placeholder
Nadim Ahmed Sells 9,922 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) CEO Nadim Ahmed sold 9,922 shares of the business's stock in a transaction dated Tuesday, December 23rd. The stock was sold at an average...
MarketBeat·22d ago
News Placeholder
Assenagon Asset Management S.A. Has $1.05 Million Stake in Cullinan Therapeutics, Inc. $CGEM
Assenagon Asset Management S.A. raised its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Free Report) by 1,665.9% in the third quarter, according to its most recent 13F filing with...
MarketBeat·27d ago
News Placeholder
Cullinan Therapeutics (NASDAQ:CGEM) Shares Gap Down - Time to Sell?
Cullinan Therapeutics (NASDAQ:CGEM) Shares Gap Down - Time to Sell...
MarketBeat·28d ago
News Placeholder
Jennifer Michaelson Sells 1,345 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jennifer Michaelson sold 1,345 shares of the firm's stock in a transaction dated Friday, December 19th. The stock was sold at an...
MarketBeat·29d ago
News Placeholder
Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $13,463.45 in Stock
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jennifer Michaelson sold 1,345 shares of the business's stock in a transaction that occurred on Friday, December 19th. The shares...
MarketBeat·29d ago
News Placeholder
Jeffrey Alan Jones Sells 4,632 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock
Cullinan Therapeutics, Inc. (NASDAQ:CGEM - Get Free Report) insider Jeffrey Alan Jones sold 4,632 shares of the business's stock in a transaction dated Thursday, December 18th. The stock was sold at...
MarketBeat·1mo ago
<
1
2
...
>

Latest CGEM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.